UAE - Mubasher: The Department of Health – Abu Dhabi (DoH) has partnered with Pfizer to promote clinical research and trials capacity in Abu Dhabi.
The collaboration is in line with Abu Dhabi's strategy to boost its position as the region's leading research and innovation hub in life science, enhance the digital health system, and foster innovation in healthcare, according to a press release on Thursday.
Under the agreement, Pfizer will enable DoH to arrange a training curriculum to boost the early phase of clinical trials and drug development programmes.
Pfizer also seeks to train up to 150 clinical researchers within two years, supporting DoH's objective to reach 500 qualified clinical researchers by 2025.
The Undersecretary of DoH, Jamal Mohammed Al Kaabi, said: "We do this by providing a legislative environment that attracts and motivates research and innovation in healthcare, enhancing the means of cooperation that join Abu Dhabi with global partners, and continuing to roll out promising clinical trials and research projects."
Meanwhile, the Gulf Cluster Lead, Lindsey Dietschi, commented: "Abu Dhabi established a robust and sustainable world-class healthcare system that fosters innovation in research and development of processes. We believe in the vision of Abu Dhabi that aims to deliver more medical breakthroughs and ensure healthier communities."
